Bristol Myers Squibb (BMY) Liabilities from Discontinued Operations (2013)

Bristol Myers Squibb (BMY) has reported Liabilities from Discontinued Operations for 1 consecutive years, with $4.9 billion the latest figure, recorded in Q4 2013.

• On a quarterly basis, Liabilities from Discontinued Operations changed N/A year-over-year to $4.9 billion in Q4 2013; TTM through Dec 2013 was $4.9 billion, a N/A change from a year earlier, with the FY2013 full-year figure at $4.9 billion, changed N/A from the prior year.
• Liabilities from Discontinued Operations was $4.9 billion for Q4 2013 at Bristol Myers Squibb.
• Over five years, Liabilities from Discontinued Operations peaked at $4.9 billion in Q4 2013 and troughed at $4.9 billion in Q4 2013.